(Total Views: 587)
Posted On: 10/21/2020 12:23:45 AM
Post# of 153886
So - the Meso GvHD CRL wasn't on him - but the locals may or may not get that.
That said, he appears to think CytoDyn is a more likely ticket to success than other immunology trials at Meso, even though stem cells are cool. It's good to hear.
That said, he appears to think CytoDyn is a more likely ticket to success than other immunology trials at Meso, even though stem cells are cool. It's good to hear.
(2)
(0)
